Biotech

All Articles

Eli Lilly jumps deeper in to AI with $409M Hereditary Jump package

.Eli Lilly has risen into an AI-enabled drug invention deal, partnering with RNA professional Geneti...

After FDA denial and also layoffs, Lykos chief executive officer is actually leaving

.Lykos CEO and founder Amy Emerson is stepping down, along with principal functioning police officer...

Novartis kindles new stage of Voyager contract along with $15M capsid offer

.Novartis is opening a brand-new outpost in its own partnership along with Voyager Therapies, paying...

Lilly articles more favorable information on its own once a week insulin possibility

.On the heels of an FDA denial for its primary competing Novo Nordisk, Eli Lilly is gaining ground i...

IN 8bio halts phase 2 trial, lays off fifty percent of workforce

.Simply a couple of months after dosing the initial person in a stage 2 test for recently detected g...

Lilly, Haya ink $1B biobuck weight problems contract to look darker genome

.Eli Lilly's look for obesity aim ats has actually led it to the dark genome. The Big Pharma has com...

ArsenalBio raises $325M, rotates out of previous lead possession

.Collection Biosciences is actually carrying on up. The tissue therapy provider has added on $325 th...

Lilly- backed weight-loss biotech data IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has actually fil...

Aelis' marijuana use medication fails period 2b, driving Indivior to review $100M choice

.Aelis Farma's hopes of safeguarding an easy, beneficial selection on a $100 million possibility pay...

ProKidney stops phase 3 trial certainly not needed for tissue therapy confirmation

.ProKidney has actually ceased one of a set of period 3 tests for its own tissue therapy for kidney ...